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GENETIC DETERMINISM OF THE FUNCTIONAL CONDITION 
OF THE ENDOTHELIUM IN PATIENTS WITH CHRONIC DIFFUSE LIVER 
DISEASES AND DISORDERS OF THYROID HOMEOSTASIS
Summary. Patients with chronic diffuse of liver disease have a violation of thyroid homeostasis in the form of 
reduction of free triiodothyronine in the blood serum, as well as thyroid stimulating hormone increasing content 
and of free thyroxin.
In patients with chronic diffuse liver diseases there is a relation between the expression of Pro197Leu 
polymorphism of GPX1 gene and indices of cellular adhesion, which is revealed by a reliably higher content of 
soluble intercellular adhesion molecule type 1 in the blood serum in homozygotic carriers of Leu-allele. Changes 
of the endothelial functional state in patients with chronic diffuse liver diseases are associated with Pro197Leu 
polymorphism of GPX1 gene, which is proved by a reliably higher index of desquamated endotheliocytes amount 
and lower level of nitric oxide metabolites in the carriers of LeuLeu-genotype.
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Introduction
Genetic polymorphism is the basis of a phenotype 
difference of peculiarities, and it can stipulate congenital 
susceptibility to various diseases. The study of this question 
draws much attention to the gene coding factors involved in 
the development of variable pathology [9, 11].
The analysis of genetic associations plays an 
important role in the examination of the role of genetic 
factors involved in the development of polymorphic 
diseases, and chronic diffuse liver disease (CDLD) in 
particular. The difference of marker allele frequency in 
patients with certain pathology and healthy individuals 
gives the evidence to draw a conclusion about the link 
between a particular allele and corresponding pathology 
[1, 3]. The information available concerning the links of 
CDLD pathogenesis allows detecting the range of genes-
candidates which potential relation with this pathology 
needs further investigation [7, 10].
Due to recent scientific research both of Ukrainian 
and foreign scientists the concept of relations between 
indices of cytokine regulation, endothelium functional 
state and expression of various genes is beyond any 
doubt [11]. Although dependence of the above indices 
upon GPX1 Pro197Leu gene polymorphism in 
patients with CDLD remains above the attention of 
researchers.
The aim the study. Peculiarities of the indices of the 
cellular adhesion and endothelial functional state in patients 
with CDLD depending on Pro197Leu polymorphism in 
GPX1 gene.
Materials and Methods
28 patients with CDLD aged from 34 to 72 were examined. 
Depending on GPX1 gene Pro197Leu polymorphism there 
were 12 homozygotes by Pro-allele, 8 — by Leu-allele and 8 
ProLeu-heterozygotes.
The diagnosis of CDLD was made on the basis of 
anamnesis, generally accepted complex of clinical-
laboratory and instrumental investigation methods, USD 
of the abdominal organs. Patients with chronic hepatitis 
and cirrhosis of a viral etiology, Wilson-Konovalov disease, 
congenital insufficiency of -antitripsin (-inhibitor 
of proteinase), idiopathic (genetic) hemochromatosis, 
autoimmune hepatitis were excluded from the study. 
Alleles of Pro197Leu regions in GPX1 gene were studied 
by means of excretion of genome DNA from leukocytes of the 
peripheral blood with further amplification of a polymorphic 
region by means of polymerase chain reaction (PCR) on the 
programmed amplificatory Amply-4L (Biocom, Moscow) 
with individual temperature program for the parameters of 
every gene. Table 1 presents succession of oligonucleotides 
in primers and their calculation positions on chromosomes.
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Table 1. Succession of oligonucleotides in primers used for polymerase chain reaction (PCR) to identify 
Pro197Leu polymorphism of GPX1 gene




DNA extraction was conducted by means of DNA-
sorb-B reagents, variant 100 (Russian) according to the 
instruction. Purified DNA was kept under the temperature 
of 20 ± 2 °C. Samples for PCR were prepared by means of 
AmplySense-200-1 set (Russian).
The content of soluble intercellular adhesion molecule 
type 1 (ICAM-1) in the blood serum was detected by 
immunoenzymatic method with the use of commercial test 
system BenderMedSystems (Austria).
Functional endothelial state was estimated by 
the content of NO metabolites and the amount of 
desquamated endothelial cells in the blood. NO content 
in the blood serum was estimated by the concentration of 
its final stable metabolite — NO
2
 and the content of total 
final metabolites NO (nitrates + nitrites). The method to 
detect NO
2
 content in the venous blood plasma is based 
on the photocolorimetric detection of optic density of 
NO
2
 stained complex by Griess test [2]. The amount of 
desquamated endothelial cells (EC) in the blood was 
estimated by J. Hladovec method in N. Petrishchev et al. 
modification [4].
Peculiarities of thyroid homeostasis were studied by 
the content of free thyroxin (fT
4
), free triiodothyronine 
(fT
3
) and thyroid stimulating hormone by means 






Immunotech) on the analyzer of immune-enzymatic 










The results obtained are calculated by means of Biostat 
program with the use of Student t-criterion.
Results
Indicators studies of thyroid homeostasis at patients 
with CDLD established a probable reduction in fТ
3
 and 
increase of the concentration in fТ
4
 due to failure of 
peripheral monodeiodization against the increasing of 
thyroid stimulating pituitary function. As evidence of this 










However, in most of the examined cases the values of the 
studied parameters did not exceed the norm.
The indices of cellular adhesion and functional 
endothelial state in patients with CDLD did experience 
reliable changes depending on polymorphism of GPX1 gene 
and were statistically different from the group of practically 
healthy individuals (Table 2).
Reliable increase of ICAM-1 content in the blood 
serum of all the groups concerning the control values was 
found: for the carriers of ProPro-genotype — on 19.1 % 
(p
1
 < 0.001), ProLeu-genotype — on 25.4 % (p1 < 0.001) 
and 49.2 % (p
1
 < 0.001) for the patients with LeuLeu-
genotype. LeuLeu-genotype carriers presented the value of 
this index on 25.3 % higher (p
1
 < 0.001) than that of the 
patients with ProPro-genotype.
Pro-allele homozygotes revealed reliable decrease of 
stable NO metabolites in the blood in 1.3 (p
1
 < 0.01) in 
comparison with the control value, Leu-allele ones — 
in 1.8 times correspondingly (p
1
 < 0.001), ProLeu-
heterozygotes — in 1.6 times (p
1
 < 0.001). Reliably lower 
level of NO metabolites (on 23.9 %, p
1
 < 0.001) was found 
in the blood of LeuLeu-genotype carriers as compared with 
the patients of ProPro-genotype.
Table 2. Indices of the endothelial function in patients with CDLD depending 
on Pro197Leu polymorphism of GPX1 gene (M ± m)
Index Control group, n = 20
Genotypes of GPX1 gene, n = 28
ProPro, n = 12 ProLeu, n = 8 LeuLeu, n = 8




351.380 ± 18.274 
p
1




387.410 ± 20.108 
p
1
 < 0.001 
p
2














11.450 ± 1.139 
p
1




10.240 ± 1.012 
p
1
 < 0.001 
p
2








5.830 ± 0.549 
p
1




6.270 ± 0.625 
p
1
 < 0.001 
p
2




Notes: n — number of observations; probability of changes concerning: p
1
 — the control; p
2
 — the group of 
patients with ProPro-genotype; p
3
 — the group of patients with ProLeu-genotype.
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While comparing the index of desquamated endothelio-
cytes amount in the blood of patients with CDLD depen-
ding on Pro197Leu of GPX1 gene with the control value its 
index has been found to increase in 1.5 times (p < 0.001) 
in the group with ProPro-genotype, in 1.9 times (p < 0.001) 
in the group of patients with ProLeu-genotype, and in 2.1 
times (p < 0.001) in the group with LeuLeu-genotype. The 
value of the given index in the blood of LeuLeu-genotype car-
riers was found to be reliably higher than that in patients with 
ProPro-genotype on 35.4 % (p < 0.05).
Thus, homozygotic carrier of Leu-allele in patients with 
CDLD is associated with a reliable higher level of ICAM-1 
in the blood serum, index of endotheliocytemia and lower 
level of NO stable metabolites.
Obtained data is consistent with the results of the last 
year’s research and shows that genetic variation in genes that 
codes enzymes of the glutathione family affect susceptibility 
to the occurrence of CDLD, one of which is the pathogenesis 
of endothelial dysfunction [1, 10]. Most researchers have 
found that certain allelic variants of glutathione peroxides 
gene may increase the likelihood of oxidative stress.
It is well-known that oxidative stress that accompanies 
the intensification of peroxidation processes and antioxidant 
imbalance background of activation is the leading 
mechanism of liver disease [2, 3, 5].
These results can be explained by increasing free radical 
oxidation processes in Pro197Leu polymorphism of GPX1 
gene carriers [11]. Free radicals are able to directly destroy 
NO [6]. Increased lipid peroxidation of membranes is the 
result of damaging the structure of the endothelium and its 
violation NO-producing ability. Developing an absolute or 
relative deficiency of NO, is required for normal regulation 
of vascular tone. The weakening of the NO-dependent 
vasodilatatory reactions, in its turn, leads to increased 
vascular tone, increased blood clots, and as a result, tissue 
hypoxia. In addition, the reduced inhibitory effect of NO on 
platelet aggregation, leukocyte adhesion to the endothelium 
and smooth muscle cell proliferation of the vascular wall, 
creates prerequisites for vascular disorders. Important 
role in the pathogenesis of endothelial dysfunction plays 
adhesion cell growth. Of particular importance in cell 
migration is given intercellular adhesion molecule type 1 — 
ICAM-1 [2]. It is known that cell adhesion is a violation of 
not only the development but also to the further progression 
of endothelial damage [6]. Progression endothelial 
dysfunction, in turn, leads to tissue hypoxia, disruption of 
metabolism and infiltration of macrophages subendothelial 
space, induction of endothelial apoptosis [5, 10], which 
is consistent with our results with respect to the growing 
number desquamated (circulating) endothelial cells in 
peripheral blood of patients studied.
Conclusions
1. Patients with chronic diffuse of liver disease have a 
violation of thyroid homeostasis in the form of reduction 
of blood serum of free triiodothyronine, as well as thyroid 
stimulating hormone increasing content and of free thyroxin.
2. In patients with CDLD there is a relation between the 
expression of Pro197Leu polymorphism of GPX1 gene and 
indices of cellular adhesion, which is revealed by a reliably 
higher content of intercellular adhesion molecules of the 1 
type in the blood serum in homozygotic carriers of Leu-allele.
3. Changes of the endothelial functional state in patients 
with chronic diffuse liver diseases are associated with 
Pro197Leu polymorphism of GPX1 gene, which is proved 
by a reliably higher index of desquamated endotheliocytes 
amount and lower level of NO metabolites in the carriers of 
LeuLeu-genotype.
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ГЕНЕТИЧЕСКАЯ ДЕТЕРМИНАЦИЯ 
ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ ЭНДОТЕЛИЯ 
У ПАЦИЕНТОВ С ХРОНИЧЕСКИМИ ДИФФУЗНЫМИ 
ЗАБОЛЕВАНИЯМИ ПЕЧЕНИ С НАРУШЕНИЕМ 
ТИРЕОИДНОГО ГОМЕОСТАЗА
Резюме. Установлено, что у пациентов с хроническими диф-
фузными заболеваниями печени происходит нарушение тире-
оидного гомеостаза в виде снижения содержания в сыворотке 
крови свободного трийодтиронина, повышения содержания 
тиреотропного гормона и свободного тироксина.
У пациентов с хроническими диффузными заболеваниями 
печени установлена связь между экспрессией Pro197Leu по-
лиморфизма гена GPX1 и показателями клеточной адгезии, 
которая проявляется достоверно более высоким содержанием 
молекулы межклеточной адгезии 1-го типа в сыворотке кро-
ви у гомозиготных носителей Leu-аллели. Изменения фун-
кционального состояния эндотелия у пациентов с хрониче-
скими диффузными заболеваниями печени ассоциируются с 
Pro197Leu полиморфизмом гена GPX1, о чем свидетельствует 
достоверно более высокий показатель количества десквамиро-
ванных эндотелиоцитов и более низкий уровень метаболитов 
оксида азота у носителей LeuLeu-генотипа.
Ключевые слова: хронические диффузные заболевания пе-
чени, тиреоидный гомеостаз, полиморфизм, эндотелий.
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ГЕНЕТИЧНА ДЕТЕРМІНАЦІЯ 
ФУНКЦІОНАЛЬНОГО СТАНУ ЕНДОТЕЛІЮ 
В ПАЦIЄНТIВ IЗ ХРОНІЧНИМИ ДИФУЗНИМИ 
ЗАХВОРЮВАННЯМИ ПЕЧІНКИ З ПОРУШЕННЯМ 
ТИРЕОЇДНОГО ГОМЕОСТАЗУ
Резюме. Установлено, що в пацiєнтiв iз хронічними дифуз-
ними захворюваннями печінки відбувається порушення тире-
оїдного гомеостазу у вигляді зниження вмісту в сироватці крові 
вільного трийодтироніну, підвищення вмісту тиреотропного 
гормону та вільного тироксину.
У пацiєнтiв iз хронічними дифузними захворюваннями 
печінки встановлено зв’язок між експресією Pro197Leu 
поліморфізму гена GPX1 та показниками клітинної ад-
гезії, що проявляється вірогідно вищим умістом моле-
кули міжклітинної адгезії 1-го типу в сироватці крові в 
гомозиготних носіїв Leu-алелi. Зміни функціонально-
го стану ендотелію в пацiєнтiв iз хронічніми дифузни-
ми захворюваннями печінки асоціюються з Pro197Leu 
поліморфізмом гена GPX1, про що свідчить вірогідно ви-
щий показник кількості десквамованих ендотеліоцитів і 
нижчий рівень метаболітів оксиду азоту в носіїв LeuLeu-
генотипу.
Ключові слова: хронічні дифузні захворювання печінки, ти-
реоїдний гомеостаз, поліморфізм, ендотелій.
